BB Biotech AG (BB BIOTECH N) aksje
BION.SW
CHF43.65-0.85 (-1.91%)
Laster graf...
BB BIOTECH N
Market Cap
$2,407,264,768
Åpning44.20
Høy44.50
Lav43.60
Volum70.16k
P/E3.00
Markedsverdi2.41B
52-ukers høy49.65
52-ukers lav29.00
Gj.sn. volum102.16k
Utbytte5.15%
Beta0.63
EPS14.55
Om BB Biotech AG (BB BIOTECH N) aksje
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Selskapsinformasjon
Børs: Swiss (EBS)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
Seestrasse 16
CH-8700 Küsnacht, Switzerland
CH-8700 Küsnacht, Switzerland
Telefon: + 41 44 2676700
Nettside: https://www.bbbiotech.ch/en/bb-biotech/
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
65.00
↑ 48.9%
Gjennomsnittlig kursmål
69.00
↑ 58.1%
Median kursmål
69.00
↑ 58.1%
Høyeste kursmål
73.00
↑ 67.2%